IGM Biosciences Inc
NASDAQ:IGMS

Watchlist Manager
IGM Biosciences Inc Logo
IGM Biosciences Inc
NASDAQ:IGMS
Watchlist
Price: 10.1 USD -9.42% Market Closed
Market Cap: 599.1m USD
Have any thoughts about
IGM Biosciences Inc?
Write Note

IGM Biosciences Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IGM Biosciences Inc
Capital Expenditures Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
IGM Biosciences Inc
NASDAQ:IGMS
Capital Expenditures
-$12.4m
CAGR 3-Years
11%
CAGR 5-Years
-73%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Capital Expenditures
-$888m
CAGR 3-Years
0%
CAGR 5-Years
-12%
CAGR 10-Years
-4%
Gilead Sciences Inc
NASDAQ:GILD
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Capital Expenditures
-$974m
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Capital Expenditures
-$481.8m
CAGR 3-Years
-30%
CAGR 5-Years
-45%
CAGR 10-Years
-25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Capital Expenditures
-$928.1m
CAGR 3-Years
-18%
CAGR 5-Years
-20%
CAGR 10-Years
-13%

See Also

What is IGM Biosciences Inc's Capital Expenditures?
Capital Expenditures
-12.4m USD

Based on the financial report for Dec 31, 2023, IGM Biosciences Inc's Capital Expenditures amounts to -12.4m USD.

What is IGM Biosciences Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-73%

Over the last year, the Capital Expenditures growth was -21%. The average annual Capital Expenditures growth rates for IGM Biosciences Inc have been 11% over the past three years , -73% over the past five years .

Back to Top